Evidence map›Paper›PMID 26288985›Full record

ArticleInfection control and hospital epidemiology2015

In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.

Samuel L Aitken, M Jahangir Alam, Mohammed Khaleduzzaman, Mohammed Khaleduzzuman, Seth T Walk, William L Musick, Vy P Pham, Jennifer L Christensen, Robert L Atmar, Yang Xie and 1 more

Erratum issuedOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Infection control and hospital epidemiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Microorganisms · 2023
    Article
  6. Article
  7. Article
  8. PCR ribotypes ofEmerging microbes & infections · 2020
    Article
  9. Article
  10. Article
  11. Clostridioides (Formerly Clostridium) difficile Infection During Hospitalization Increases the Likelihood of Nonhome Patient Discharge.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  12. Article
  13. EpidemicOpen forum infectious diseases · 2019
    Article
  14. Proteotyping ofFrontiers in microbiology · 2019
    Article
  15. Observational
  16. Article
  17. Control ofMicrobiology spectrum · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Samuel L Aitken1Department of Pharmacy Practice and Translational Research,University of Houston College of Pharmacy,Houston,Texas.
M Jahangir Alam1Department of Pharmacy Practice and Translational Research,University of Houston College of Pharmacy,Houston,Texas.
Mohammed Khaleduzzaman
Mohammed Khaleduzzuman1Department of Pharmacy Practice and Translational Research,University of Houston College of Pharmacy,Houston,Texas.
Seth T Walk3Department of Microbiology and Immunology,Montana State University,Bozeman,Montana.
William L Musick2Department of Pharmacy,Houston Methodist Hospital,Houston,Texas.
Vy P Pham4Department of Pharmacy,Memorial Hermann Northwest Hospital,Houston,Texas.
Jennifer L Christensen5Department of Internal Medicine,Baylor College of Medicine Houston,Texas.
Robert L Atmar6Department of Medicine,Section of Infectious Disease,Baylor College of Medicine Houston,Texas.
Yang Xie7Merck & Co.,Whitehouse Station,New Jersey.
Kevin W Garey1Department of Pharmacy Practice and Translational Research,University of Houston College of Pharmacy,Houston,Texas.
University of Houston · USBaylor College of Medicine · USMemorial Hermann Northwest Hospital · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USMethodist Hospital · USMontana State University · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Phylogenomic epidemiology of Clostridium difficileK01AI097281 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WALK, SETH T · 2012 to 2016
$509k
NIAID NIH HHS K01 AI097281NIAID NIH HHS K01AI097281NIDDK NIH HHS P30 DK056338
6 · The paper itself

Abstract

backgroundConflicting reports have been published on the association between Clostridium difficile ribotypes and severe disease outcomes in patients with C. difficile infection (CDI); several so-called hypervirulent ribotypes have been described. We performed a multicenter study to assess severe disease presentation and severe outcomes among CDI patients infected with different ribotypes.

methodsStool samples that tested positive for C. difficile toxin were collected and cultured from patients who presented to any of 7 different hospitals in Houston, Texas (2011-2013). C. difficile was characterized using a fluorescent PCR ribotyping method. Medical records were reviewed to determine clinical characteristics and ribotype association with severe CDI presentation (ie, leukocytosis and/or hypoalbuminemia) and severe CDI outcomes (ie, ICU admission, ileus, toxic megacolon, colectomy, and/or in-hospital death).

resultsOur study included 715 patients aged 61±18 years (female: 63%; median Charlson comorbidity index: 2.5±2.4; hospital-onset CDI: 45%; severe CDI: 36.7%; severe CDI outcomes: 12.3%). The most common ribotypes were 027, 014-020, FP311, 002, 078-126, and 001. Ribotype 027 was a significant independent predictor of severe disease (adjusted odds ratio [aOR], 2.24; 95% confidence interval [CI], 1.53-3.29; P<.001) and severe CDI outcomes (aOR, 1.71; 95% CI, 1.02-2.85; P=.041) compared with all other ribotypes in aggregate. However, in an analysis using all common ribotypes as individual variables, ribotype 027 was not associated with severe CDI outcomes more often than other ribotypes.

conclusionRibotype 027 showed virulence equal to that of other ribotypes identified in this endemic setting. Clinical severity markers of CDI may be more predictive of severe CDI outcomes than a particular ribotype.

Indexed as

AdultAgedAged, 80 and overClostridioides difficileClostridium InfectionsCross InfectionFemaleHospitalsHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisOdds RatioProspective StudiesRibotyping

Identifiers

PMID26288985
PMCPMC4710480
OpenAlexW2124462639

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.